 |
Market Research Report
Oncology Market Size By Cancer Diagnostics & Treatment, By Cancer Type, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026 |
||||||
| Published by | Global Market Insights Inc. | Product code | 976201 | ||||
| Published | Content info | 246 Pages Delivery time: 2-3 business days |
|||||
| Price |
|
||||||
| Oncology Market Size By Cancer Diagnostics & Treatment, By Cancer Type, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026 | ||
| Published: December 14, 2020 | Content info: 246 Pages |
|
Title:
Oncology Market Size By Cancer Diagnostics & Treatment (Cancer Diagnostics {Tumor Biomarker Test, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization}, Cancer Treatment {Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy}), By Cancer Type (Lung Cancer, Prostate Cancer, Colon & Rectal Cancer, Gastric Cancer, Esophageal Cancer, Liver Cancer, Breast Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026.
The global oncology market is rapidly emerging as one of the most lucrative verticals within the healthcare and medical devices space and it is expected to record substantial gains in the future. Future trends and developments in the industry will be driven by the exponential rise in the number of cancer cases across the globe. Considering the importance of early detection in the treatment of cancer, different cancer diagnostic and therapeutic solutions are expected to be in demand over the next few years.
Cancer continues to be one of the leading causes of death worldwide. Surprisingly, the occurrence of cancer is higher in countries where people have a higher education level, standard of living, and life expectancy. The overall rate of deaths associated with cancer has been dropping over the years and the number of cancer survivors has increased considerably. These trends indicate that progress has been made in the field of oncology. However, a lot of work still needs to be done to make significant progress against the disease.
In many countries, the rates of smoking, which is a leading cause of cancer, have declined on account of growing health consciousness. However, the rates of other risk factors such as obesity is still pretty high in many regions. In addition, the global population is aging and it is no surprise that the risk of cancer increases with age. These factors will certainly augment the global oncology industry forecast over the next few years.
The cancer treatment market is poised to surpass an annual valuation of approximately US$285 billion by the end of 2026. These trends can be associated with ongoing research and development activities along with constant technological advances in cancer treatment methods such as radiotherapy and chemotherapy.
The global oncology industry share from colon & rectal cancer was estimated to be worth over US$22.5 billion in 2019 and it is estimated to grow substantially in the near future. Colorectal cancer, also known as colon cancer, rectal cancer, or bowel cancer, is among the leading causes of death in both men and women.
Considering the end-user, specialty clinics accounted for more than 5.1% of the global oncology market in 2019 and will continue to hold a fair share of the market in the forthcoming years. The consumer preference towards specialty clinics has been growing significantly.
Patients at specialty clinics have access to robust expertise, treatment, and resources that aren't available in general hospitals. These clinics have years of experience in treating people with specific conditions. They provide patients with access to diagnosis, treatment, medical devices, equipment, and resources required to meet their specific needs.
In terms of the regional outlook, the oncology market in Latin America is slated to hit an annual valuation of more than US$30.6 billion by 2026.
Global Academic and Non-Profit Partnering Terms and Agreements 2015-2021
Global Animal Health Partnering Terms and Agreements 2010 to 2021
Global Big Pharma Partnering Terms and Agreements 2014-2021
Global Biotech Partnering Terms and Agreements 2017-2021
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2021
Global Infectious Diseases Partnering 2014-2021: Deal trends, players and financials
Global Metabolic Partnering 2014-2020: Deal trends, players and financials
Global Pediatrics Partnering 2010-2021: Deal trends, players and financials
Global Pharmaceutical Partnering Terms and Agreements 2017-2021